Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Back

ESC Premium Access

Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Session: Poster session 1 - Risk stratification and prognosis after TAVI

Topic: Aortic valve disease

Speaker: Professor R. Waksman (Washington, DC, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Ron Waksman

Washington Hospital Center & Medstar Health, Washington, DC (United States of America)

3 presentations

0 follower

10 more presentations in this session

Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.

Speaker: Doctor M. Perrone (Rome, IT)

Access

Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI

Speaker: Doctor H. Hioki (Tokyo, JP)

Access

Abstract

Slides

Transcatheter aortic valve replacement alters expression levels of circulating myocardial microRNAs

Speaker: Doctor F. Jansen (Bonn, DE)

Access

Abstract

Slides

Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

Speaker: Mrs A. Stundl (Bonn, DE)

Access

Abstract

Slides

Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi

Speaker: Mrs A. Stundl (Bonn, DE)

Access

Abstract

Slides

Access the full session

Poster session 1 - Risk stratification and prognosis after TAVI

Speakers: Professor R. Waksman, Doctor M. Perrone, Doctor H. Hioki, Doctor F. Jansen, Mrs A. Stundl...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources